Literature DB >> 8321792

Left ventricular wall thickness and disease duration in systemic sclerosis.

I Hegedüs1, L Czirják.   

Abstract

Myocardial thickness, left ventricular functions, and right heart overloading were investigated in 80 patients with systemic sclerosis by echocardiography. Based on the left ventricular wall thickness, three groups were formed. Fifteen patients with asymmetrical left ventricular wall hypertrophy (Group 1) showed shorter mean disease duration with marked diastolic and mild systolic left ventricular functional impairment. The 25 patients with wall thinning (Group 3) had a slight increase in left ventricular diameters, impaired systolic functions and longer disease duration. Group 2 with wall thickness exhibited mixed changes. Patients with increased wall thickness tended to have a shorter disease duration than patients with wall thinning. Patients with systemic sclerosis showed systolic and diastolic function impairment as compared to the 18 control healthy individuals. Pericardial disease was found in 23 cases (28.7%).

Entities:  

Mesh:

Year:  1993        PMID: 8321792      PMCID: PMC2399657          DOI: 10.1136/pgmj.69.810.285

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  29 in total

1.  Scleroderma (systemic sclerosis): classification, subsets and pathogenesis.

Authors:  E C LeRoy; C Black; R Fleischmajer; S Jablonska; T Krieg; T A Medsger; N Rowell; F Wollheim
Journal:  J Rheumatol       Date:  1988-02       Impact factor: 4.666

2.  Clinical findings in 61 patients with progressive systemic sclerosis.

Authors:  L Czirják; A Bokk; G Csontos; G Lörincz; G Szegedi
Journal:  Acta Derm Venereol       Date:  1989       Impact factor: 4.437

3.  Cold-induced reversible myocardial ischaemia in systemic sclerosis.

Authors:  R Gustafsson; F Mannting; E Kazzam; A Waldenström; R Hällgren
Journal:  Lancet       Date:  1989-08-26       Impact factor: 79.321

4.  Cardiac involvement in systemic sclerosis.

Authors:  A J Geirsson; B Blom-Bülow; O Pahlm; A Akesson
Journal:  Semin Arthritis Rheum       Date:  1989-10       Impact factor: 5.532

Review 5.  The pulmonary pathologic manifestations of the CREST syndrome.

Authors:  S A Yousem
Journal:  Hum Pathol       Date:  1990-05       Impact factor: 3.466

6.  Prediction of survival in progressive systemic sclerosis by multivariate analysis of clinical features.

Authors:  J Wynn; N Fineberg; L Matzer; X Cortada; W Armstrong; J C Dillon; E L Kinney
Journal:  Am Heart J       Date:  1985-07       Impact factor: 4.749

7.  Prognostic importance of cardiac arrhythmias in systemic sclerosis.

Authors:  J B Kostis; J R Seibold; D Turkevich; A T Masi; R G Grau; T A Medsger; V D Steen; P J Clements; L Szydlo; W A D'Angelo
Journal:  Am J Med       Date:  1988-06       Impact factor: 4.965

8.  Nifedipine and thallium-201 myocardial perfusion in progressive systemic sclerosis.

Authors:  A Kahan; J Y Devaux; B Amor; C J Menkès; S Weber; A Nitenberg; A Venot; F Guérin; M Degeorges; J C Roucayrol
Journal:  N Engl J Med       Date:  1986-05-29       Impact factor: 91.245

9.  Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis.

Authors:  A M Stupi; V D Steen; G R Owens; E L Barnes; G P Rodnan; T A Medsger
Journal:  Arthritis Rheum       Date:  1986-04

10.  Left ventricular dysfunction induced by cold exposure in patients with systemic sclerosis.

Authors:  W W Ellis; A N Baer; R M Robertson; T Pincus; M W Kronenberg
Journal:  Am J Med       Date:  1986-03       Impact factor: 4.965

View more
  1 in total

1.  Left ventricular wall motion abnormalities in 80 patients with systemic sclerosis.

Authors:  I Hegedüs; L Czirják
Journal:  Clin Rheumatol       Date:  1995-03       Impact factor: 2.980

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.